Drug Type Shared antigen vaccine |
Synonyms Ad5 [E1-, E2b-]-HER2/neu Vaccine, ETBX 021 |
Target |
Mechanism HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Phase 2 | US | 01 Aug 2018 | |
Colorectal Cancer | Phase 2 | US | 25 May 2018 | |
Non-Small Cell Lung Cancer | Phase 2 | - | 01 Feb 2018 | |
Ovarian Cancer | Phase 2 | - | 01 Dec 2017 | |
Squamous Cell Carcinoma of Head and Neck | Phase 2 | - | 01 Dec 2017 | |
Transitional Cell Carcinoma | Phase 2 | - | 01 Dec 2017 | |
Locally Advanced Unresectable Breast Carcinoma | Phase 1 | US | 01 Dec 2016 |